Acacia Pharma Announces Excellent Phase II Results For Post-operative Nausea and Vomiting Product (News)
19:45 EDT 31 May 2012 | OBN
28 May 2012: Cambridge, UK – Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV). The study showed that ...
Original Article: Acacia Pharma Announces Excellent Phase II Results For Post-operative Nausea and Vomiting Product (News)
More From BioPortfolio on "Acacia Pharma Announces Excellent Phase II Results For Post-operative Nausea and Vomiting Product (News)"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
